Oncology Pharma Inc
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated … Read more
Oncology Pharma Inc (ONPH) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2022: -0.002x
Based on the latest financial reports, Oncology Pharma Inc (ONPH) has a cash flow conversion efficiency ratio of -0.002x as of December 2022.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.98K) by net assets ($1.10 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Oncology Pharma Inc - Cash Flow Conversion Efficiency Trend (1996–2022)
This chart illustrates how Oncology Pharma Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Oncology Pharma Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Oncology Pharma Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NanoTech Gaming Inc
PINK:NTGL
|
-0.407x |
|
ComF5 International Inc
PINK:CMFV
|
0.316x |
|
KAL Energy Inc
PINK:KALG
|
-0.034x |
|
Sharpe Resources Corporation
PINK:SHGP
|
0.001x |
|
Mansfelder Metals Ltd
PINK:MNSF
|
-0.123x |
|
Consolidated Eco-Systems Inc
PINK:EXSO
|
-0.107x |
|
All World Resources Corporation
PINK:AWRS
|
-0.208x |
|
Terra Energy & Resource Technologies Inc
PINK:TEGR
|
-0.035x |
Annual Cash Flow Conversion Efficiency for Oncology Pharma Inc (1996–2022)
The table below shows the annual cash flow conversion efficiency of Oncology Pharma Inc from 1996 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-03-31 | $1.25 Million | $368.61K | 0.296x | -57.08% |
| 2021-03-31 | $-170.01K | $-117.08K | 0.689x | +95.60% |
| 2020-03-31 | $-63.66K | $-22.41K | 0.352x | +102.82% |
| 2019-03-31 | $-212.62K | $-36.91K | 0.174x | +641.73% |
| 2013-03-31 | $-220.27K | $7.06K | -0.032x | -83.54% |
| 2011-03-31 | $-404.27K | $7.06K | -0.017x | -100.15% |
| 2004-03-31 | $-172.00K | $-2.00 Million | 11.628x | +802.18% |
| 2003-03-31 | $872.00K | $-1.44 Million | -1.656x | -170.89% |
| 2002-03-31 | $2.37 Million | $-1.45 Million | -0.611x | -60.98% |
| 2001-03-31 | $3.69 Million | $-1.40 Million | -0.380x | +44.24% |
| 2000-03-31 | $5.02 Million | $-3.42 Million | -0.681x | -102.22% |
| 1998-03-31 | $-55.66K | $-1.71 Million | 30.656x | +496.30% |
| 1997-03-31 | $326.38K | $-2.52 Million | -7.736x | -643.24% |
| 1996-03-31 | $1.81 Million | $-1.88 Million | -1.041x | -- |